J B Chemicals & Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|
Revenue | 914.87 | 920.67 | 964.65 |
Operating Expense | 670.36 | 668.11 | 687.58 |
Net Profit | 149.80 | 156.39 | 173.12 |
Net Profit Margin | 16.37 | 16.99 | 17.95 |
Earning Per Share | 9.63 | 10.06 | 11.15 |
EBIDTA | 238.73 | 242.87 | 268.03 |
Effective Tax Rate | 17.83 | 17.20 | 18.78 |
Particulars | Mar 2025 |
---|---|
Revenue | 914.87 |
Operating Expense | 670.36 |
Net Profit | 149.80 |
Net Profit Margin | 16.37 |
Earning Per Share | 9.63 |
EBIDTA | 238.73 |
Effective Tax Rate | 17.83 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Total Revenue Annual | 3,722.92 | 3,298.64 | 2,884.16 |
Operating Expenses Annual | 2,704.99 | 2,419.23 | 2,219.47 |
Operating Profit Annual | 1,052.67 | 914.09 | 673.34 |
Interest Annual | 9.12 | 40.52 | 34.31 |
Depreciation | 166.45 | 135.24 | 111.99 |
Net Profit Annual | 652.54 | 543.36 | 388.89 |
Tax Annual | 224.56 | 194.98 | 138.15 |
Particulars | Mar 2025 |
---|---|
Total Revenue Annual | 3,722.92 |
Operating Expenses Annual | 2,704.99 |
Operating Profit Annual | 1,052.67 |
Interest Annual | 9.12 |
Depreciation | 166.45 |
Net Profit Annual | 652.54 |
Tax Annual | 224.56 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Cash Flow at the Beginning | 56.37 | 53.88 | 37.69 |
Cash Flow from Operations | 884.03 | 789.03 | 628.64 |
Cash Flow from Investing | -289.93 | -412.47 | -955.86 |
Cash Flow from Financing | -574.27 | -374.08 | 343.41 |
Cash Flow at the End | 76.21 | 56.37 | 53.88 |
Particulars | Mar 2025 |
---|---|
Cash Flow at the Beginning | 56.37 |
Cash Flow from Operations | 884.03 |
Cash Flow from Investing | -289.93 |
Cash Flow from Financing | -574.27 |
Cash Flow at the End | 76.21 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
PBDIT Margin (%) | 28.28 | 27.71 | 23.35 |
PBIT Margin (%) | 23.80 | 23.61 | 19.46 |
PBT Margin (%) | 21.19 | 23.03 | 18.89 |
Net PROFIT Margin (%) | 17.53 | 16.47 | 13.48 |
Return On Networth / Equity (%) | 20.84 | 20.39 | 17.11 |
Return On Networth /Employed (%) | 26.54 | 24.83 | 21.68 |
Return On Assets (%) | 19.46 | 17.30 | 14.97 |
Total Debt / Equity (X) | 0.06 | 0.17 | 0.13 |
Asset Turnover Ratio (%) | 1.11 | 1.05 | 1.11 |
Particulars | Mar 2025 |
---|---|
PBDIT Margin (%) | 28.28 |
PBIT Margin (%) | 23.80 |
PBT Margin (%) | 21.19 |
Net PROFIT Margin (%) | 17.53 |
Return On Networth / Equity (%) | 20.84 |
Return On Networth /Employed (%) | 26.54 |
Return On Assets (%) | 19.46 |
Total Debt / Equity (X) | 0.06 |
Asset Turnover Ratio (%) | 1.11 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Fixed Assets Annual | 1,899.03 | 1,938.16 | 1,832.40 |
Total Current Assets Annual | 1,778.65 | 1,715.40 | 1,398.30 |
Non Current Assets Annual | 2,399.24 | 2,198.24 | 2,071.85 |
Total Shareholders Funds Annual | 3,377.19 | 2,886.26 | 2,442.48 |
Total Assets Annual | 4,177.90 | 3,913.64 | 3,470.15 |
Particulars | Mar 2025 |
---|---|
Fixed Assets Annual | 1,899.03 |
Total Current Assets Annual | 1,778.65 |
Non Current Assets Annual | 2,399.24 |
Total Shareholders Funds Annual | 3,377.19 |
Total Assets Annual | 4,177.90 |
EPS (INR)
Expected
9.36
Reported
9.36
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.10%
Jun 2024
EPS beaten by 0.00%